What is BioDelivery Sciences International Price-to-Operating-Cash-Flow?
As of today (2024-05-27), BioDelivery Sciences International's share price is €5.05.
BioDelivery Sciences International's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2021 was €0.34. Hence, BioDelivery Sciences International's Price-to-Operating-Cash-Flow Ratio for today is 14.90.
The historical rank and industry rank for BioDelivery Sciences International's Price-to-Operating-Cash-Flow or its related term are showing as below:
FRA:BD5'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.52 Med: 12.38 Max: 55
Current: 14.08
During the past 13 years, BioDelivery Sciences International's highest Price-to-Operating-Cash-Flow Ratio was 55.00. The lowest was 4.52. And the median was 12.38.
BioDelivery Sciences International's Cash Flow from Operations per share for the
three
months ended in Dec. 2021 was €0.12.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2021 was €0.34.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of BioDelivery Sciences International was 66.80% per year.
During the past 13 years, BioDelivery Sciences International's highest 3-Year average Operating Cash Flow per Share Growth Rate was 17.90% per year. The lowest was -75.20% per year. And the median was -19.75% per year.
BioDelivery Sciences International Price-to-Operating-Cash-Flow Historical Data
The historical data trend for BioDelivery Sciences International's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioDelivery Sciences International Price-to-Operating-Cash-Flow Chart
|
BioDelivery Sciences International Annual Data
|
|
Trend |
Dec12 |
Dec13 |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
- |
- |
47.52 |
17.65 |
7.81 |
|
BioDelivery Sciences International Quarterly Data
|
|
Mar17 |
Jun17 |
Sep17 |
Dec17 |
Mar18 |
Jun18 |
Sep18 |
Dec18 |
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
17.65 |
13.91 |
9.32 |
9.84 |
7.81 |
Competitive Comparison of BioDelivery Sciences International's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, BioDelivery Sciences International's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioDelivery Sciences International's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, BioDelivery Sciences International's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where BioDelivery Sciences International's Price-to-Operating-Cash-Flow falls into.
BioDelivery Sciences International Price-to-Operating-Cash-Flow Calculation
BioDelivery Sciences International's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 5.05 | / | 0.339 |
| = | 14.90 |
BioDelivery Sciences International's Share Price of today is €5.05.
BioDelivery Sciences International's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.34.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
BioDelivery Sciences International (FRA:BD5) Business Description
Traded in Other Exchanges
N/A
Address
4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612
BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.
BioDelivery Sciences International (FRA:BD5) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:BD5 has been successfully added to your